Showing 1–12 of 29 results

Eltrombo-25

Eltrombopag Olamine 25mg

Eltrombo-50

Eltrombopag Olamine 50mg

INDENZA 160

COMPOSITION: Each tablet contains Enzalutamide 160 mg INDENZA is indicated for • Metastatic Castration Resistant Prostate Cancer • Metastatic High

OLABIR 150MG TABLETS

Ovarian Cancer For the maintenance treatment of adult patients with recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer, who

OLABIR 150MG TABLETS OLAPARIB

Ovarian Cancer For the maintenance treatment of adult patients with recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer, who

Palbocib-125

Palbociclib capsules 125 mg

Pazokast 200

Pazopanib Tablets 200 mg

Pazokast 400

Pazopanib Tablets 400 mg

TEMZOKEY 100MG

COMPOSITION: Each hard gelatin capsule contains: Temozolomide IP 100 mg INDICATIONS AND USAGE: TEMZOKEY capsules are indicated in the treatment

TEMZOKEY 400mg

COMPOSITION: Each hard gelatin capsule contains: Temozolomide IP 400 mg INDICATIONS AND USAGE: TEMZOKEY capsules are indicated in the treatment

THALINEW

COMPOSITION : Each hard gelatin capsule contains: Thalidomide USP 100 mg INDICATIONS • Thalidomide is primarily indicated for the acute

ABIRAKAST

Abiraterone Acetate Tablets IP 250 mg

Leading the Way in Oral Oncology Care Solutions

We are the largest manufacturer, exporter, and supplier of oral oncology care solutions.

Oral solid dosage forms remain the edge in cancer treatment for maintenance therapy, targeted therapy, and outpatient convenience.

At our state-of-the-art manufacturing facility, we develop more than 30 products focused on treating various cancers, including breast cancer, lung cancer, blood cancer, colorectal cancer, and testicular cancers.

Our oncology oral therapeutics set the benchmark in affordable, high-quality care accessible to all.

Complex Therapeutics Expertise:

We are capable of manufacturing complex therapeutics including:

  • • Modified-release and immediate-release tablets and capsules
  • • Using high-quality excipients and APIs
  • • Ensuring maximum solubility and bioavailability

Front Runners in the Oncology Care Landscape

We manufacture a complete range of oncology oral products, including chemotherapy drugs, immunotherapy drugs, hormonal therapy drugs, and targeted therapy drugs.

Most Prescribed and In-Demand Brands

Our flagship products include:

  • • Dorucin-50
  • • Eltrombo-50
  • • Palbocib-125

Global Leaders in Oncology Care

We have been the largest exporter of oncology oral tablets and capsules, with footprints in more than 20 countries across South east Asia, South America, Africa, and all CIS countries.
We continue to resource the next generation of therapeutics, integrating cutting-edge technologies.